Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246012
Status:
COMPLETED
Last Update Posted:
2013-08-19
First Post:
2005-10-28
Brief Title:
A Safety and Efficacy Study of Intetumumab Alone and in Combination With Dacarbazine in Participants With Stage 4 Melanoma
Sponsor:
Centocor Inc
Organization:
Centocor Inc
Organization Data
Organization:
Centocor Inc
Class:
INDUSTRY
Study ID:
CR006004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centocor Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen-Cilag Farmaceutica SRL | UNKNOWN |